A Kinetic Mechanism for the Polymerization of alpha 1-Antitrypsin*

Timothy R. DaffornDagger §, Ravi MahadevaDagger , Peter R. ElliottDagger , Pasupathy SivasothyDagger parallel , and David A. LomasDagger

From the Dagger  Department of Haematology and  Respiratory Medicine Unit, Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/Medical Research Council Building, Hills Road, Cambridge CB2 2XY, United Kingdom

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The mutation in the Z deficiency variant of alpha 1-antitrypsin perturbs the structure of the protein to allow a unique intermolecular linkage. These loop-sheet polymers are retained within the endoplasmic reticulum of hepatocytes to form inclusions that are associated with neonatal hepatitis, juvenile cirrhosis, and hepatocellular carcinoma. The process of polymer formation has been investigated here by intrinsic tryptophan fluorescence, fluorescence polarization, circular dichroic spectra and extrinsic fluorescence with 8-anilino-1-naphthalenesulfonic acid and tetramethylrhodamine-5-iodoacetamide. These biophysical techniques have demonstrated that alpha 1-antitrypsin polymerization is a two-stage process and have allowed the calculation of rates for both of these steps. The initial fast phase is unimolecular and likely to represent temperature-induced protein unfolding, while the slow phase is bimolecular and associated with loop-sheet interaction and polymer formation. The naturally occurring Z, S, and I variants and recombinant site-directed reactive loop and shutter domain mutants of alpha 1-antitrypsin were used to demonstrate the close association between protein stability and rate of alpha 1-antitrypsin polymerization. Taken together, these data allow us to propose a kinetic mechanism for alpha 1-antitrypsin polymer formation that involves the generation of an unstable intermediate, which can form polymers or generate latent protein.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

alpha 1-Antitrypsin is a member of the serpin protein superfamily that encompasses a wide range of serine proteinase inhibitors involved in coagulation, inflammation, fibrinolysis, and the complement cascade (1-3). The members of the superfamily have a common tertiary structure based on a central beta -sheet (sheet A), surrounded by two other sheets (B and C) and a mobile, inhibitory reactive center loop (Fig. 1). The mechanism of action of these proteins as proteinase inhibitors is most unusual in comparison to other serine protease inhibitors, as cleavage of the P1-P1' bond by non-target enzymes causes a large rearrangement of the serpin with the loop incorporated into the A beta -sheet and the P1 and P1' residues separated by over 60 Å (4-6). The loop may be stably incorporated into the A beta -sheet in the absence of cleavage by formation of the latent species (7-10). This is typically prepared by heating serpins for prolonged periods in the presence of stabilizing concentrations of sodium citrate (8, 10, 11). The description of this conformational change from x-ray crystal structures of the native (7, 8, 12-15), latent (7-9), and cleaved (4-6, 16) forms of the serpins, combined with the fact that the cleaved and latent forms have a much higher stability compared with the native species (10, 17-20), has led to the suggestion that the serpin fold is metastable (21, 22).


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 1.   A ribbon representation of the alpha 1-antitrypsin fold viewed from two orientations with the reactive center loop in bold. Following reactive loop cleavage and the formation of the latent species, the loop is incorporated into the A beta -sheet as s4A. Trp-194 in s3A, Trp-238 in s2B, Cys-232 in s1B, and Glu-342 in s5A are shown, and sheets A, B, and C and helix A are marked for orientation. The shutter domain, which controls opening of the gap between s3A and s5A and loop insertion, is shown as a dotted line. The proximal hinge region of the reactive loop is centered on Glu-342 and labeled P, and the distal hinge is labeled D. The figure was produced using MOLSCRIPT (47).

In 1992, we showed that severe deficiency of the Z variant of alpha 1-antitrypsin (Glu-342 right-arrow Lys) resulted from a conformational transition and a unique linkage between the reactive center loop of one molecule and a beta -sheet of a second (23). This process of polymer formation was temperature- and concentration-dependent (23, 24), and the polymers that formed had the appearance of "beads on a string" when visualized by electron microscopy (25). Since this initial report, investigations have been concerned with the characterization and classification of clinically relevant mutations. These studies have shown that polymerization can occur with a variety of deficiency mutants of alpha 1-antitrypsin (25-27) and in variants of antithrombin (28, 29) and C1-inhibitor (30, 31) in association with thrombosis and angioedema, respectively. The structural mechanism by which serpin self-assembly occurs has not yet been determined, but biophysical data show that the polymeric form has an enhanced stability like that of the cleaved form of alpha 1-antitrypsin (10, 26, 32). Peptides with homology to the reactive center loop can insert into the A beta -sheet of the native molecule to block polymerization in vitro (23, 24, 32), and these data suggest that polymerization occurs by sequential insertion of the reactive loop from one molecule into the A-sheet of another. X-ray crystal structures of a dimer of antithrombin have revealed an alternative intermolecular linkage between the reactive center loop of one molecule and the C beta -sheet of a second (7, 8, 33). The precise mechanism associated with disease remains uncertain, and although both A- and C-sheet linkages can form in conditions that are dependent on the buffer (10, 34), the recent structures of native alpha 1-antitrypsin (13, 15) give support to a reactive loop:A beta -sheet interaction in vivo.

We report here the molecular dynamics of alpha 1-antitrypsin polymer formation. Such a study is important, as it is now becoming apparent that a deeper understanding of the mechanism of polymerization is required to allow the production of mimetics to control diseases caused by serpin misassembly.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Purification of alpha 1-Antitrypsin-- alpha 1-Antitrypsin was purified from human plasma by 50% and 75% ammonium sulfate fractionation, followed by thiol exchange and Q-Sepharose chromatography as detailed previously (24). alpha 1-Antitrypsin was also expressed in Escherichia coli using the expression vector pWombAT (35) and was purified from the crude E. coli cell extract by 8% and 28% w/v PEG1 8000 fractionation. The resulting pellet was resuspended in 20 mM phosphate buffer, pH 6.8, containing 5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 1% (v/v) beta -mercaptoethanol and subjected to PAE300 chromatographic separation, the protein being eluted off the column by a 0-0.4 M NaCl gradient. Fractions containing alpha 1-antitrypsin were then further purified using zinc-chelating Sepharose (equilibrated in 50 mM Tris-HCl, 150 mM NaCl, pH 8.5) and eluting with a 0-75 mM glycine gradient. Finally, the fractions containing alpha 1-antitrypsin were loaded onto a 5,5'-dithiobis(2-nitrobenzoic acid)-charged glutathione-Sepharose column (equilibrated in 100 mM Tris, 5 mM EDTA, pH 8.0), and eluted with 15 ml of 5,5'-dithiobis(2-nitrobenzoic acid)/dithiothreitol (24).

The proteins were stored in 50 mM Tris, 50 mM KCl, pH 7.4, and their concentration quantified by measurements of UV absorbance at 280 nm with an extinction coefficient (1 mg/ml) of 0.53. Purity was confirmed by 7.5-15% (w/v) SDS- polyacrylamide gel electrophoresis (PAGE) and 7.5-15% (w/v) non-denaturing PAGE.

Preparation of Conformations of alpha 1-Antitrypsin-- M alpha 1-antitrypsin polymers were prepared by heating plasma M alpha 1-antitrypsin (0.25 mg/ml) at 60 °C for 3 h as described previously (24) and were confirmed by non-denaturing PAGE and a complete loss of inhibitory activity against bovine alpha -chymotrypsin (10). Cleaved alpha 1-antitrypsin was prepared by incubation with Staphylococcus aureus V8 proteinase (24), which cleaves at the P4-P5 bond of the reactive loop, and full cleavage was confirmed by a 4-kDa band shift on SDS-PAGE. Latent alpha 1-antitrypsin was prepared by heating at 67 °C in 0.7 M citrate for 12 h as detailed previously (10).

Fluorescence Measurements-- Fluorescence measurements were made using a Perkin Elmer LS 50B spectrofluorimeter. Intrinsic tryptophan fluorescence of alpha 1-antitrypsin was measured in 20 mM sodium phosphate, 100 mM NaCl, 0.1 mM EDTA, and 0.1% (w/v) PEG 8000, pH 7.4, using an excitation wavelength of 295 nm and detecting photons emitted at 90o to the excitation beam. Wherever possible, the slits controlling the intensity of the excitation light source were kept at the minimum machine-permissible limit of 2.5 nm; any other values for these slit widths were as detailed in the text. Emission slit widths were varied between 2.5 and 15 nm, dependent on the experimental conditions in order to give an optimal emission signal. The majority of experiments used a 0.5-ml cuvette with a path length of 1 cm on the excitation axis and 0.2 cm on the emission axis. Throughout all experiments the sample temperature was maintained by a heated water jacket within the cuvette holder, the temperatures quoted within the text being those within the cuvette.

Fluorescence Polarization-- Polarization experiments were carried out in 20 mM sodium phosphate, 100 mM NaCl, 0.1 mM EDTA, and 0.1% w/v PEG 8000, pH 7.4, using the same system as that for the fluorescence measurements with the addition of plane polarizing filters between the light source and the sample and between the sample and the detector. Measurements were made on a single sample with five repeat measurements for each time point with the polarizers in the parallel and perpendicular positions. A value for the fluorescence polarization was calculated from two samples using Equation 1 (see Ref. 36).
P=<FR><NU>I<SUB><UP>vv</UP></SUB>−G · I<SUB><UP>vh</UP></SUB></NU><DE>I<SUB><UP>vv</UP></SUB>+G · I<SUB><UP>vh</UP></SUB></DE></FR> (Eq. 1)
P is the polarization of the sample, Ivv and Ivh are the parallel and perpendicular components of the fluorescence signal, and G is the instrument factor for the machine that normalizes the polarization introduced by the optical components of the detection system.

Production of Tetramethylrhodamine-5-iodoacetamide (5-TMRIA)-labeled alpha 1-Antitrypsin-- The single cysteine of plasma alpha 1-antitrypsin was labeled with 5-TMRIA according to the manufacturer's instructions (Molecular Probes, Inc.) This gave a labeling efficiency of 20%. Changes in the fluorescence characteristics of the probe during alpha 1-antitrypsin polymerization were measured in 20 mM sodium phosphate, 100 mM NaCl, 0.1 mM EDTA, and 0.1% w/v PEG 8000, pH 7.4, by exciting at 543 nm and measuring light emitted at 567 nm. The results are the average of eight polymerization experiments.

8-Anilino-1-naphthalenesulfonic Acid (ANSA) Binding-- A saturated solution of ANSA was prepared in 50 mM Tris, 50 mM KCl, pH 7.4, and filtered through a 0.2-µm pore size filter. Fifty µl of this stock solution was added to 500 µl of 20 mM sodium phosphate, 100 mM NaCl, 0.1 mM EDTA, and 0.1% (w/v) PEG 8000, pH 7.4, in a fluorescence cuvette. The experiment was initiated by the addition of alpha 1-antitrypsin (typically 50 µl) to the cuvette to give a final concentration of 0.1 mg/ml. The fluorescence changes of the ANSA during alpha 1-antitrypsin polymerization were then measured by exciting with light at 370 nm and detecting fluorescence at 450 nm.

Circular Dichroism-- Circular dichroism (CD) experiments were undertaken using a JASCO J-720 spectrapolarimeter. Samples were prepared using 50 mM phosphate buffer (pH 7.4), and CD spectra of samples were collected using a 0.05-cm path length quartz cuvette at an alpha 1-antitrypsin concentration of 0.5 mg/ml. Changes in the secondary structure of alpha 1-antitrypsin with time and temperature were measured by monitoring the CD signal at 222 nm with the protein at 0.5 mg/ml in 50 mM phosphate, pH 7.4. The temperature within the cuvette was maintained by a computer-controlled water bath connected to a water jacket integral to the cuvette holder, and monitored by a sensor directly located in the holder. Thermal unfolding experiments were performed using a heating rate of 60 °C/h and measuring the change in signal at 222 nm. The second derivative of the resulting data was then used to calculate the inflection point of the transition and hence Tm.

Data Fitting-- The kinetic data were fitted to single or double exponential functions of the following type:
F=A0<SUB>1</SUB>(1−e<SUP><UP>−</UP>k<SUB>1</SUB>t</SUP>) (Eq. 2)
for a single transition (Equation 2) or
F=A0<SUB>1</SUB>(1−e<SUP><UP>−</UP>k<SUB>1</SUB>t</SUP>)+A0<SUB>2</SUB>(1−e<SUP><UP>−</UP>k<SUB><UP>app</UP></SUB>t</SUP>) (Eq. 3)
for a double transition (Equation 3), where A01 and A02 are the amplitudes of the phase, with rates of k1 and kapp, and t is time. The choice of the curve used in the fit was determined by the one that gave the smallest residuals when compared with the experimental data. The best fit was calculated using Grafit (version 3.00, 1992, Erithracus Software Ltd).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Intrinsic Tryptophan Fluorescence-- The polymerization of alpha 1-antitrypsin is both concentration- and temperature-dependent (24). Plasma alpha 1-antitrypsin was incubated over a range of temperatures and concentrations to obtain the optimum conditions for the assessment of rates of polymer formation by intrinsic tryptophan fluorescence. At temperatures over 50 °C, the rates were too fast to dissect out the different phases of polymerization, and at lower temperatures, the rate was too slow to be assessed during a 24-h incubation. At 45 °C and 0.1 mg/ml, there was an increase in intrinsic tryptophan fluorescence (Fig. 2a) and a 2.5-nm blue shift, which was 50% complete by 36,000 s (10 h), 80% complete by 80,000 s (22 h), and 95% complete after 151,200 s (42 h). Mathematical analysis of the change in the fluorescence intensity with time revealed a fast and slow exponential phase. Examination of the protein at various time points throughout polymerization by non-denaturing PAGE showed no high molecular mass species in the first 7200 s (2 h; Fig. 2b) and then a rate of decrease in intensity of the native band, which agreed well with the slower rate calculated from intrinsic tryptophan fluorescence (Fig. 2c). In order to demonstrate the specificity of these signals, the experiment was repeated with alpha 1-antitrypsin cleaved at the reactive center loop. This form is unable to undergo polymerization (24) and showed no change in tryptophan fluorescence when incubated under the same conditions. The phenomena reported by the tryptophan fluorophores during the fast and slow phase of polymerization were assessed with a variety of other spectroscopic methods (Table I).


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2.   Panel a, measurement of the changes in conformation of plasma alpha 1-antitrypsin during polymerization at 0.1 mg/ml and 45 °C by intrinsic tryptophan fluorescence produced by exciting the fluorophore at 295 nm with a slit width of 2.5 nm and measuring emitted light at 340 nm through a 6.0-nm slit. Inset shows the fast signal change between 0 and 6000 s in more detail. Panel b, silver-stained 7.5-15% non-denaturing PAGEs, which showed the increase in polymeric species with time in association with the slow phase of polymerization. Each lane contained 3 µg of protein. Panel b: lane 1, 0 s; lane 2, 7200 s (2 h); lane 3, 14,400 s (4 h); lane 4, 21,600 s (6 h); lane 5, 28,800 s (8 h); lane 6, 36,000 s (10 h); lane 7, 43,200 s (12 h); lane 8, 172,800 s (48 h). Panel c: lane 1, 0 s; lane 2, 21,600 s (6 h); lane 3, 64,800 s (18 h); lane 4, 151,000 s (42 h); lane 5, 237,000 s (66 h); lane 6, 327,000 s (91 h); lane 7, 432,000 s (120 h).

                              
View this table:
[in this window]
[in a new window]
 
Table I
A summary of the rates of various signals recorded during polymerization of 0.1 mg/ml alpha 1-antitrypsin at 45 °C
The rates were obtained by fitting the data to either the single or double exponential function in Equation 2 or 3. ND, not defined with this technique.

Fluorescence Polarization-- Measurement of the polarization of the fluorescence from tryptophans within the protein showed a decrease in fluorescence polarization with time (Fig. 3a). This indicates an increase in the speed of motion of the tryptophans and may be explained by either an increase in the rate of motion of this moiety within the protein scaffold or a decrease in tumbling time of the protein overall (36). The rate of decrease in fluorescence polarization over 6000 s was similar to the rate of the fast phase observed with intrinsic tryptophan fluorescence (Table I). The slow phase was not resolved with this technique.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   Measurement of the changes in conformation of plasma alpha 1-antitrypsin during polymerization at 0.1 mg/ml and 45 °C. Panel a, tryptophan fluorescence polarization. Panel b, fluorescence produced by exciting covalently linked rhodamine at 492 nm with a slit width of 2.5 nm and measuring emitted light at 540 nm through an 6.0 nm slit. Inset is the fluorescence profile for the first 1000 s. Panel c, the fluorescence produced by exciting ANSA at 370 nm with a slit width of 2.5 nm and measuring emitted light at 450 nm through an 8.0-nm slit. Inset shows the increase in fluorescence between 0 and 10,000 s, which corresponds to the fast phase of Fig. 2a.

Extrinsic Fluorescence-- The changes in properties of alpha 1-antitrypsin during polymer formation were assessed following labeling of cysteine 232 (Fig. 1) with an extrinsic rhodamine probe, 5-TMRIA. The fluorophore reported an increase in fluorescence and a 2.0-nm blue shift with a rate constant similar to that of the slow phase detailed previously (Fig. 3b). The fast phase could not be resolved with this technique. These data indicate that the fluorophore at position 232 has become more protected from solvent as the protein polymerizes.

The dye ANSA was also used to probe the conformational changes of alpha 1-antitrypsin during polymerization, as its fluorescence is sensitive to changes in protein surface hydrophobicity (37). Measurements of ANSA fluorescence during polymerization show an initial small fast fluorescence enhancement (Fig. 3c), followed by a larger decrease in fluorescence which occurs at a rate close to that of the slow phase. These data show that in the early stages of the experiment alpha 1-antitrypsin transiently exposes hydrophobic domains before the slow reburial of these exposed residues.

Circular Dichroism-- Changes in the far-UV CD spectra were observed between the five-stranded native and the six-stranded reactive loop cleaved and latent forms of alpha 1-antitrypsin (Fig. 4a). An increase in the magnitude of the signal at 222 nm was observed as alpha 1-antitrypsin formed polymers when incubated at 0.1 mg/ml and 45 °C (Fig. 4b). These data were the mean of five experiments and allowed the calculation of a fast phase (Table I), which closely matched that observed by intrinsic fluorescence. Spectra were also taken at the beginning of the experiment and after 24 h when the polymerization was 80% complete as assessed by change in fluorescence signal (Fig. 4a). This shows a decrease in intensity at 222 nm (the region associated with alpha -helix content) of only 0.25 × 10-3 millidegrees cm2 dmol-1, which is compatible with alpha 1-antitrypsin polymerization. Polymers were also prepared by heating alpha 1-antitrypsin at 0.25 mg/ml at 50 °C for 12 h in 50 mM Tris, 50 mM KCl, pH 7.4 (Fig. 4c). The far-UV CD profile of these polymers was significantly more negative than that of native alpha 1-antitrypsin and alpha 1-antitrypsin polymers formed at 45 °C (Fig. 4a).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Panel a, far-UV CD spectra of native (thick line), cleaved (thin dashed line), and latent (thin continuous line) conformations of plasma alpha 1-antitrypsin and a sample of loop-sheet polymers (shown with x) formed by heating at 0.25 mg/ml at 50 °C for 12 h. The spectra were measured using a 0.05-cm path length cuvette at a speed of 50 nm/min and averaged over five repetitions. The change in CD spectra that occurs during the polymerization of plasma alpha 1-antitrypsin at 45 °C and 0.1 mg/ml is shown between t = 0 (thick line) and t = 24 h (thin dotted line) and was measured in a 0.1-cm path length cuvette. The rate of change is shown in panel b, which reports the change in CD signal at 222 nm with respect to time. Panel c, 7.5-15% (w/v) non-denaturing PAGE to show the conformations of plasma alpha 1-antitrypsin assessed by circular dichroic spectra. All lanes contain 2 µg of protein. Lane 1, native alpha 1-antitrypsin; lane 2, reactive loop cleaved alpha 1-antitrypsin; lane 3, alpha 1-antitrypsin polymerized at 0.25 mg/ml at 50 °C for 12 h; lane 4, latent alpha 1-antitrypsin.

The Concentration Dependence of the Fast and Slow Phase of Polymerization-- Previous studies have shown that the overall rate of alpha 1-antitrypsin polymer formation was dependent on protein concentration (24). The fast phase of the fluorescence signal during polymerization was unaffected by protein concentration, confirming that the process was unimolecular (data not shown). The slow rate did show dependence on concentration, which became non-linear at high protein concentrations (Fig. 5). Incubation of alpha 1-antitrypsin at 0.1 mg/ml and 45 °C with stabilizing sodium citrate, which favors the formation of the latent protein, reduced the rate of polymerization by approximately 15-fold (Fig. 5).


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 5.   The effect of plasma alpha 1-antitrypsin concentration on the slow rate of polymer formation detected by intrinsic tryptophan fluorescence at 45 °C. Closed circles, without citrate; filled circles, with 0.5 M citrate.

pH Dependence of Polymerization-- The results obtained during these studies suggest that increasing the conformational flexibility of alpha 1-antitrypsin plays an important role in increasing the proteins' propensity to polymerize. This was further assessed by changing the solution pH to destabilize the protein and assessing the rate of polymerization with intrinsic fluorescence. The rate of polymerization was measured at pH 5, 6, 7, 8, and 9 using buffers with protonation states that were insensitive to temperature changes. Rates of polymerization were considerably increased at high and low pH (Fig. 6a), and this was associated with reduced melting temperatures as assessed by CD spectra at 222 nm (Fig. 6b).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 6.   Panel a, rates of alpha 1-antitrypsin polymer formation over a range of pH. The rates were determined by measuring the change in intrinsic tryptophan fluorescence of a 0.1 mg/ml solution of plasma alpha 1-antitrypsin at 45 °C, exciting at 295 nm (2.5-nm slit) and measuring light emitted at 340 nm (6.0-nm slit). The resulting data were fitted to Equation 3 and kapp obtained as the polymerization rate. Panel b, the melting points of alpha 1-antitrypsin at different pH values were measured by monitoring the CD signal at 222 nm while increasing the sample temperature at 60 °C/h. Inset is a plot of the melting point obtained versus the solution pH.

Effect of Point Mutations on Rates of Polymerization-- Our interest in the polymerization of alpha 1-antitrypsin results from its association with plasma deficiency, cirrhosis, and emphysema (38). Thus detailed studies of the effect of medically relevant mutations on the protein's behavior are important. In this study, we have taken advantage of the availability of such mutants and have studied their propensity for polymerization using the methods detailed above. Six alpha 1-antitrypsin variants were used in this study, which represent both naturally occurring variants purified directly from blood plasma (Z, S, I, and M alpha 1-antitrypsin) and mutations introduced into a recombinant framework (wild type, Phe-51 right-arrow Leu, Glu-354 right-arrow Gln, and Glu-354 right-arrow Ser alpha 1-antitrypsin) and expressed in E. coli. Analysis of these variants showed that an increased rate of polymer formation by the protein correlated with a reduced melting temperature (Table II).

                              
View this table:
[in this window]
[in a new window]
 
Table II
The polymerization rates for naturally occurring and recombinant mutants of alpha 1-antitrypsin at 45 °C and 0.1 mg/ml measured by the change in intrinsic tryptophan fluorescence with time
The melting temperature (Tm) of 0.5 mg/ml alpha 1-antitrypsin was obtained by measuring the change in ellipticity at 222 nm with respect to sample temperature, which was increased at a rate of 60 °C/h between 25 and 95 °C. The polymerisation rates were obtained by fitting the data from intrinsic tryptophan fluorescence to Equation 3, and the Tm values were calculated as detailed under "Experimental Procedures." The results are presented in decreasing value of Tm to show the inverse relationship with rate of polymer formation. WT, wild type.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The primary objective of this study was a detailed analysis of the process of alpha 1-antitrypsin polymer formation. The data from tryptophan fluorescence and the extrinsic probe ANSA showed that there were two processes with 10-fold different rates during polymer formation. The faster of the two processes was independent of protein concentration and was observed as the sole process during the measurement of fluorescence polarization and circular dichroism. This is consistent with a conformational change occurring within the protein induced by a change in temperature. This process did not alter the fluorescent characteristics of the rhodamine probe bound to Cys-232 in the C-sheet, implying that the conformational change occurs elsewhere in the protein. The change in tryptophan fluorescence must result from the perturbation of tryptophan residues at either 194 or 238 (Fig. 1). Trp-238 is on the surface of alpha 1-antitrypsin, 6.5 Å from Cys-232, with no stable hydrogen bonds visible in the native structure (13, 15). It seems improbable that a conformational change within the protein could increase the fluorescence of Trp-238, and indeed site-directed mutagenesis has shown that this residue makes no contribution to tryptophan fluorescence on refolding of alpha 1-antitrypsin (39). Thus, increasing temperature perturbs the environment of Trp-194 in alpha 1-antitrypsin, reflecting disorganization of the strands at the top of the A beta -sheet.

The slower of the two processes was also observed as changes in tryptophan and ANSA fluorescence and the fluorescence of rhodamine linked to Cys-232. This process is dependent on protein concentration and was associated with the formation of high molecular mass loop-sheet polymers on non-denaturing PAGE. The fact that the fluorescence of a moiety attached to the C-sheet is affected during polymer formation is consistent with the proximity of the residue to the reactive loop, which provides the "linker" segment in models of loop-sheet polymers (13, 40). Although the slow phase of polymer formation was dependent on protein concentration, at high concentrations the process was saturated (Fig. 5). This suggests that, at high concentrations, a second process, such as nonspecific aggregation competes with polymer formation. On the basis of these results, we propose the following kinetic mechanism for the polymerization of a serpin.
<AR><R><C></C><C><UP><B>1</B></UP></C><C></C><C></C><C></C><C><UP><B>2</B></UP></C></R><R><C></C><C>k<SUB>1</SUB></C><C></C><C></C><C></C><C>k<SUB>2</SUB></C></R><R><C><UP>M</UP>+<UP>M</UP></C><C>→</C><C><UP>M</UP>*</C><C><UP>+</UP></C><C><UP>M</UP>*</C><C>→</C><C><UP>P</UP></C></R><R><C></C><C></C><C>k<SUB>3</SUB></C><C>↓</C><C><UP><B>3</B></UP></C></R><R><C></C><C></C><C></C><C><UP>L</UP></C></R></AR>
<UP><SC>Scheme</SC> I</UP>
Step 1 represents the conformational change of the serpin to a polymerogenic monomeric form (M*), step 2 represents the formation of polymers (P), and step 3 represents a side pathway that leads to the formation of the latent conformation (L).

If polymer formation is a two-step process, then we would expect the rate of conversion from M to P (k2) to be dependent on the concentration of M* and hence the rate of M right-arrow M* (k1). Our data show that the difference in rates between the two processes is on the order of 10-fold (Table I). Thus, following the initiation of the reaction, there should be a short lag in the production of P as the concentration of M* rises. Two of our experiments measure only the production of P: non-denaturing PAGE and rhodamine fluorescence. Rhodamine fluorescence indeed shows a small lag in the increase in signal (Fig. 3b, inset) in the early stages of the experiment, which would agree well with a build-up of M*. As further proof, comparisons of simulations of the production of P with time (using numerical solutions to differential equations describing the above mechanism), with the data from rhodamine fluorescence show good agreement. Parameters extracted from these simulations also give a value for k1 (5.2 × 10-4 s-1) that is very similar to those shown in Table I. Further to this, non-denaturing gels shows no higher molecular weight species forming in the first 7200 s, again suggesting a lag in the formation of polymers. Taken together, these data support the proposal that polymerization is a sequential two-step process: an initial fast conformational change within the protein producing a polymergenic intermediate, which then undergoes loop-sheet linkage.

Incubation of alpha 1-antitrypsin with sodium citrate favors the formation of the latent species (10, 11, 34). In order to investigate this, alpha 1-antitrypsin was incubated with sodium citrate. The concentration of citrate (0.7 M) routinely used to produce latent alpha 1-antitrypsin (17) disrupted fluorescence measurements due to solution turbidity. A lower concentration of citrate was therefore used (0.5 M), which produced insufficient latent alpha 1-antitrypsin to be visualized by non-denaturing PAGE. Despite this, the citrate reduced the rate of polymerization by an average of 15-fold (Fig. 5). This suggests that the action of citrate (even when present at a suboptimal concentration) was to reduce the value of k2 and favor the formation of latent protein.

This kinetic scheme also allows the interpretation of the effects of destabilization of the protein by extremes of pH and mutations on the rate of conformational change (Fig. 6 and Table II). Any factor that decreases protein stability (as assessed by a reduced melting temperature) will result in an increase in the equilibrium concentration of M* and so will increase the formation of both polymers and the latent conformation. Naturally occurring deficiency mutants of the serpins cluster in the shutter domain (Siiyama and Mmalton alpha 1-antitrypsin) and the proximal (Z alpha 1-antitrypsin) and distal hinge regions (38). These have been predicted to open the A beta -sheet of the protein, thereby increasing M* and favoring the formation of polymeric and latent protein at lower activation temperatures (21, 38). Mutants that increase the stability of the serpins (such as Phe-51 right-arrow Leu alpha 1-antitrypsin) will reduce M* and so reduce conversion to the latent or polymerized conformation (22, 41). Thus, it is possible to explain the observation that mutant serpins with reduced thermal stabilities more readily undergo polymerization (Table II).

Circular dichroism may be used to assess conformational transitions of proteins and major differences are apparent in the far UV spectra between the native (five-stranded) and cleaved (six-stranded) forms of the inhibitory serpins (18). This technique was therefore used to assess a second six-stranded species, latent alpha 1-antitrypsin, with the anticipation that it would be similar to the cleaved form (Fig. 4a). Surprisingly, the CD profile of latent alpha 1-antitrypsin was very different from cleaved alpha 1-antitrypsin, which suggests that the reactive loop may not be fully inserted into the A beta -sheet in the latent species or that the position of s1C is important in the far-UV CD profile, as it will be fixed in the C-sheet in the cleaved structure (4) but must be displaced in latent alpha 1-antitrypsin (8). The change in CD signal at 222 nm was also used to assess the conformational change that was associated with polymerization and gave a fast rate that was very similar to that obtained by intrinsic fluorescence (Fig. 4b and Table I). The far-UV CD profile of alpha 1-antitrypsin polymerized at 45 °C for 24 h was markedly different from that obtained after polymerizing alpha 1-antitrypsin at 50 °C and 0.25 mg/ml for 12 h (Fig. 4a). The polymers formed at 50 °C are longer (10), and the tendency to aggregate makes it difficult to accurately determine protein concentration and thereby the position of the CD profile in relation to native alpha 1-antitrypsin.

The phenomena of proteins self-assembling to form a polymeric structure may be mechanistically classified into two subtypes (42). The first type represents those most commonly encountered in which self-assembly is mediated by surface interactions between folded proteins. This sort of interaction causes sickle cell hemoglobin to polymerize and proteins to crystallize. The second type of self-assembly has been studied with great interest over the past few years, as it is central to the mechanisms of the transmissible spongiform encephalopathies and Alzheimer's disease. The self-assembly event of alpha 1-antitrypsin fits well with this form of oligomerization (43), as alpha 1-antitrypsin polymerization, like the amyloid protein transthyretin (44-46), is enhanced by destabilizing the structure of the protein with extremes of pH and point mutations. It also seems reasonable to think of native alpha 1-antitrypsin as a folding intermediate (21, 22), albeit a very stable one with the end product of the folding pathway being the six-stranded latent form of the protein.

In summary, we present here a detailed analysis of the processes underlying the polymerization of alpha 1-antitrypsin, linking a variety of spectroscopic signals to changes that occur within the protein. We have also investigated the effect that mutations which interfere with these processes have on polymerization, and have reinforced the link between serpin polymerization and amyloid-like self-assembly.

    ACKNOWLEDGEMENTS

We are grateful to James A. Huntington and Robin W. Carrell for critical appraisal of the manuscript.

    FOOTNOTES

* This work was supported by the Wellcome Trust, Medical Research Council (United Kingdom), the Cystic Fibrosis Trust, and Papworth National Health Service Trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 44-1223-336829; Fax: 44-1223-336827; E-mail: td214{at}cam.ac.uk.

parallel A Medical Research Council Training Fellow.

    ABBREVIATIONS

The abbreviations used are: PEG, polyethylene glycol; PAGE, polyacrylamide gel electrophoresis; 5-TMRIA, tetramethylrhodamine-5-iodoacetamide; ANSA, 8-anilino-1-naphthalenesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
  1. Travis, J., and Salvesen, G. S. (1983) Annu. Rev. Biochem. 52, 655-709[CrossRef][Medline] [Order article via Infotrieve]
  2. Gettins, P., Patston, P. A., and Schapira, M. (1993) BioEssays 15, 461-467[Medline] [Order article via Infotrieve]
  3. Potempa, J., Korzus, E., and Travis, J. (1994) J. Biol. Chem. 269, 15957-15960[Free Full Text]
  4. Loebermann, H., Tokuoka, R., Deisenhofer, J., and Huber, R. (1984) J. Mol. Biol. 177, 531-556[Medline] [Order article via Infotrieve]
  5. Baumann, U., Huber, R., Bode, W., Grosse, D., Lesjak, M., and Laurell, C.-B. (1991) J. Mol. Biol. 218, 595-606[Medline] [Order article via Infotrieve]
  6. Baumann, U., Bode, W., Huber, R., Travis, J., and Potempa, J. (1992) J. Mol. Biol. 226, 1207-1218[Medline] [Order article via Infotrieve]
  7. Schreuder, H. A., de Boer, B., Dijkema, R., Mulders, J., Theunissen, H. J. M., Grootenhuis, P. D. J., and Hol, W. G. J. (1994) Nat. Struct. Biol. 1, 48-54[Medline] [Order article via Infotrieve]
  8. Carrell, R. W., Stein, P. E., Fermi, G., and Wardell, M. R. (1994) Structure 2, 257-270[Abstract]
  9. Mottonen, J., Strand, A., Symersky, J., Sweet, R. M., Danley, D. E., Geoghegan, K. F., Gerard, R. D., and Goldsmith, E. J. (1992) Nature 355, 270-273[CrossRef][Medline] [Order article via Infotrieve]
  10. Lomas, D. A., Elliott, P. R., Chang, W.-S. W., Wardell, M. R., and Carrell, R. W. (1995) J. Biol. Chem. 270, 5282-5288[Abstract/Free Full Text]
  11. Lomas, D. A., Elliott, P. R., and Carrell, R. W. (1997) Eur. Respir. J. 10, 672-675[Abstract/Free Full Text]
  12. Wei, A., Rubin, H., Cooperman, B. S., Schechter, N., and Christianson, D. W. (1992) J. Mol. Biol. 226, 273-276[Medline] [Order article via Infotrieve]
  13. Elliott, P. R., Lomas, D. A., Carrell, R. W., and Abrahams, J.-P. (1996) Nat. Struct. Biol. 3, 676-681[Medline] [Order article via Infotrieve]
  14. Ryu, S.-E., Choi, H.-J., Kwon, K.-S., Lee, K. N., and Yu, M.-H. (1996) Structure 4, 1181-1192[Medline] [Order article via Infotrieve]
  15. Elliott, P. R., Abrahams, J.-P., and Lomas, D. A. (1998) J. Mol. Biol. 275, 419-425[CrossRef][Medline] [Order article via Infotrieve]
  16. Aertgeerts, K., De Bondt, H. L., De Ranter, C. J., and Declerck, P. J. (1995) Nat. Struct. Biol. 2, 891-897[Medline] [Order article via Infotrieve]
  17. Carrell, R. W., and Owen, M. C. (1985) Nature 317, 730-732[Medline] [Order article via Infotrieve]
  18. Bruch, M., Weiss, V., and Engel, J. (1988) J. Biol. Chem. 263, 16626-16630[Abstract/Free Full Text]
  19. Lawrence, D. A., Olson, S. T., Palaniappan, S., and Ginsburg, D. (1994) J. Biol. Chem. 269, 27657-27662[Abstract/Free Full Text]
  20. Chang, W.-S. W., and Lomas, D. A. (1998) J. Biol. Chem. 273, 3695-3701[Abstract/Free Full Text]
  21. Yu, M.-H., Lee, K. N., and Kim, J. (1995) Nat. Struct. Biol. 2, 363-367[Medline] [Order article via Infotrieve]
  22. Lee, K. N., Park, S. D., and Yu, M.-H. (1996) Nat. Struct. Biol. 3, 497-500[Medline] [Order article via Infotrieve]
  23. Lomas, D. A., Evans, D. L., Finch, J. T., and Carrell, R. W. (1992) Nature 357, 605-607[CrossRef][Medline] [Order article via Infotrieve]
  24. Lomas, D. A., Evans, D. L., Stone, S. R., Chang, W.-S. W., and Carrell, R. W. (1993) Biochemistry 32, 500-508[Medline] [Order article via Infotrieve]
  25. Lomas, D. A., Finch, J. T., Seyama, K., Nukiwa, T., and Carrell, R. W. (1993) J. Biol. Chem. 268, 15333-15335[Abstract/Free Full Text]
  26. Lomas, D. A., Elliott, P. R., Sidhar, S. K., Foreman, R. C., Finch, J. T., Cox, D. W., Whisstock, J. C., and Carrell, R. W. (1995) J. Biol. Chem. 270, 16864-16870[Abstract/Free Full Text]
  27. Elliott, P. R., Stein, P. E., Bilton, D., Carrell, R. W., and Lomas, D. A. (1996) Nat. Struct. Biol. 3, 910-911[Medline] [Order article via Infotrieve]
  28. Bruce, D., Perry, D. J., Borg, J.-Y., Carrell, R. W., and Wardell, M. R. (1994) J. Clin. Invest. 94, 2265-2274[Medline] [Order article via Infotrieve]
  29. Lindo, V. S., Kakkar, V. V., Learmonth, M., Melissari, E., Zappacosta, F., Panico, M., and Morris, H. R. (1995) Br. J. Haematol. 89, 589-601[Medline] [Order article via Infotrieve]
  30. Aulak, K. S., Eldering, E., Hack, C. E., Lubbers, Y. P. T., Harrison, R. A., Mast, A., Cicardi, M., and Davis, A. E., III (1993) J. Biol. Chem. 268, 18088-18094[Abstract/Free Full Text]
  31. Eldering, E., Verpy, E., Roem, D., Meo, T., and Tosi, M. (1995) J. Biol. Chem. 270, 2579-2587[Abstract/Free Full Text]
  32. Mast, A. E., Enghild, J. J., and Salvesen, G. (1992) Biochemistry 31, 2720-2728[Medline] [Order article via Infotrieve]
  33. Skinner, R., Abrahams, J.-P., Whisstock, J. C., Lesk, A. M., Carrell, R. W., and Wardell, M. R. (1997) J. Mol. Biol. 266, 601-609[CrossRef][Medline] [Order article via Infotrieve]
  34. Koloczek, H., Banbula, A., Salvesen, G. S., and Potempa, J. (1996) Protein Sci. 5, 2226-2235[Abstract/Free Full Text]
  35. Hopkins, P. C. R., Carrell, R. W., and Stone, S. R. (1993) Biochemistry 32, 7650-7657[Medline] [Order article via Infotrieve]
  36. Jameson, D. M., and Sawyer, W. H. (1995) Methods Enzymol. 246, 283-301[Medline] [Order article via Infotrieve]
  37. Busby, T. F., Atha, D. H., and Ingham, K. C. (1981) J. Biol. Chem. 256, 12140-12147[Abstract/Free Full Text]
  38. Stein, P. E., and Carrell, R. W. (1995) Nat. Struct. Biol. 2, 96-113[Medline] [Order article via Infotrieve]
  39. Kim, D., and Yu, M.-H. (1996) Biochem. Biophys. Res. Commun. 226, 378-384[CrossRef][Medline] [Order article via Infotrieve]
  40. Chang, W.-S. W., Whisstock, J., Hopkins, P. C. R., Lesk, A. M., Carrell, R. W., and Wardell, M. R. (1997) Protein Sci. 6, 89-98[Abstract/Free Full Text]
  41. Berkenpas, M. B., Lawrence, D. A., and Ginsburg, D. (1995) EMBO J. 14, 2969-2977[Abstract]
  42. Kelly, J. W. (1997) Structure 5, 595-600[Medline] [Order article via Infotrieve]
  43. Carrell, R. W., and Lomas, D. A. (1997) Lancet 350, 134-138[CrossRef][Medline] [Order article via Infotrieve]
  44. Kelly, J. W. (1996) Curr. Opin. Struct. Biol. 6, 11-17[CrossRef][Medline] [Order article via Infotrieve]
  45. McCutchen, S., Colon, W., and Kelly, J. W. (1993) Biochemistry 32, 12119-12127[Medline] [Order article via Infotrieve]
  46. McCutchen, S. L., Lai, Z., Miroy, G., Kelly, J. W., and Colon, W. (1995) Biochemistry 34, 13527-13536[Medline] [Order article via Infotrieve]
  47. Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 946-950 [CrossRef]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.